|
(S)-N-[(1S,2R,3E,5E,7S,9E,11E,13S,15R,19R)-7,13-Dihydroxy-1,4,10,19-tetramethyl-17,18-dioxo-16-oxabicyclo[13.2.2]nonadeca-3,5,9,11-tetren-2-yl]-2-hydroxypropanamide Suppliers list
|
|
| | (S)-N-[(1S,2R,3E,5E,7S,9E,11E,13S,15R,19R)-7,13-Dihydroxy-1,4,10,19-tetramethyl-17,18-dioxo-16-oxabicyclo[13.2.2]nonadeca-3,5,9,11-tetren-2-yl]-2-hydroxypropanamide Basic information |
| Product Name: | (S)-N-[(1S,2R,3E,5E,7S,9E,11E,13S,15R,19R)-7,13-Dihydroxy-1,4,10,19-tetramethyl-17,18-dioxo-16-oxabicyclo[13.2.2]nonadeca-3,5,9,11-tetren-2-yl]-2-hydroxypropanamide | | Synonyms: | (S)-N-[(1S,2R,3E,5E,7S,9E,11E,13S,15R,19R)-7,13-Dihydroxy-1,4,10,19-tetramethyl-17,18-dioxo-16-oxabicyclo[13.2.2]nonadeca-3,5,9,11-tetren-2-yl]-2-hydroxypropanamide;Antibiotic T-2636F;Lankacidinol;T-2636F;Propanamide, N-[(1S,2R,3E,5E,7S,9E,11E,13S,15R,19R)-7,13-dihydroxy-1,4,10,19-tetramethyl-17,18-dioxo-16-oxabicyclo[13.2.2]nonadeca-3,5,9,11-tetraen-2-yl]-2-hydroxy-, (2S)- | | CAS: | 23498-37-5 | | MF: | C25H35NO7 | | MW: | 461.55 | | EINECS: | | | Product Categories: | | | Mol File: | 23498-37-5.mol | ![(S)-N-[(1S,2R,3E,5E,7S,9E,11E,13S,15R,19R)-7,13-Dihydroxy-1,4,10,19-tetramethyl-17,18-dioxo-16-oxabicyclo[13.2.2]nonadeca-3,5,9,11-tetren-2-yl]-2-hydroxypropanamide Structure](CAS/GIF/23498-37-5.gif) |
| | (S)-N-[(1S,2R,3E,5E,7S,9E,11E,13S,15R,19R)-7,13-Dihydroxy-1,4,10,19-tetramethyl-17,18-dioxo-16-oxabicyclo[13.2.2]nonadeca-3,5,9,11-tetren-2-yl]-2-hydroxypropanamide Chemical Properties |
| | (S)-N-[(1S,2R,3E,5E,7S,9E,11E,13S,15R,19R)-7,13-Dihydroxy-1,4,10,19-tetramethyl-17,18-dioxo-16-oxabicyclo[13.2.2]nonadeca-3,5,9,11-tetren-2-yl]-2-hydroxypropanamide Usage And Synthesis |
| Uses | Lankacidinol (T-2636 F) is an antibiotic. Lankacidinol and its related metabolites 2,18-seco-lankacidinol A (1) and 2,18-seco-lankacidinol B (2) have significant biological activities and potential medicinal value. In addition, 2,18-seco-lankacidinol A exhibits potent antitumor activity. | | References | [1] Studies on T-2636 antibiotics. II Isolation and chemical properties of T-2636 antibiotics |
| | (S)-N-[(1S,2R,3E,5E,7S,9E,11E,13S,15R,19R)-7,13-Dihydroxy-1,4,10,19-tetramethyl-17,18-dioxo-16-oxabicyclo[13.2.2]nonadeca-3,5,9,11-tetren-2-yl]-2-hydroxypropanamide Preparation Products And Raw materials |
|